Searched for
MNC ROCHE
Epic saga of Cipla: How a swadeshi Robin Hood took on Big Pharma of the WestCipla has been closely associated with India's struggle for independence, with Khwaja Abdul Hamied forming the company in 1935. For the Big...- Times Most Influential Personalities 2021- 1
- Roche, Emcure may end pact to make 2 blockbuster drugsEmcure is still the distributor for those two drugs in India. Roche had handed out the manufacturing and marketing of trastuzumab and ritux...
- Roche vs Indian Pharma: The battle for a cheaper cancer drugThe companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first ...
- Government set to release revised biosimilar guidelines in July 2016The ministry expects the final guidelines to uphold the safety and efficacy of biosimilar drugs hitting the Indian market through stringent...
- MNC drug companies like Roche, Merck Serono, Novartis see top deck reshuffleThese companies not only had to battle slow growth but also the fickle stand of Indian government over issues of intellectual property and ...
- Individual cases to dictate MNC drug cos’ approach to patentsRoche’s decision to give up India patent for Herceptin unlikely to set a precedent, says MNC drug companies’ body.
- Little support for pharma MNCs on patent issueThe flexibilities are there and they have never been questioned by anyone in the WTO.
- Merck unit sues Glenmark Pharmaceuticals for infringing patent on diabetes drugsA unit of US drugmaker Merck & Co sued India's Glenmark Pharmaceuticals on Tuesday for infringing its patent on two diabetes drugs.
- Will continue selling Nexavar drug post IPAB verdict: Bhaskar Narayana, Natco PharmaIn an interview with ET Now, Bhaskar Narayana, Finance-Director, Natco Pharma, talks about the IPAB’s verdict on Natco’s cancer drug case a...
- Four growth drivers beyond patent for pharma companies like Sun Pharma, SanofiIt is not just Big Pharma that has to prepare for life after the 'patent cliff'' patent expiries on a slew of blockbuster drugs.
- Azad resents to lobbying against patent laws by MNCsHealth minister has objected to recent lobbying attempts by global drugmakers to change India's intellectual property rules.
- Meet Mr. Right Timing: Ajay PiramalIn terms of valuation, Abbott purchase of Piramal's healthcare unit is far ambitious than Daiichi Sankyo’s purchase of Ranbaxy. Full covera...
- Novartis to challenge IPAB’s patent decision on GlivecThe Indian subsidiary of Swiss drugmaker Novartis will challenge a decision by the Intellectual Property Appellate Board (IPAB) that said i...
- Novartis not ready to give up on GlivecThe Indian subsidiary of Swiss drugmaker Novartis will challenge a decision by the Intellectual Property Appellate Board (IPAB) that said i...
- Cancer drugs may come under NPPA lensCancer drugs may soon come under the purview of India’s drug price regulator, as they have become too expensive for the common man to affor...
- MNC pharma firms told to launch latest drugs in IndiaThe government has asked MNC pharma companies to launch latest drugs in India.
- Blogs provide window to pharmaceutical industry in IndiaDiscussions are posted by bloggers on ayurveda, biogenerics, combination drugs, patents, HIV as well as individual pharma cos. Scripting In...
- MNCs marrying into India Inc face patent testMNCs going in for mergers and acquisitions will soon be required to divest some of their patented technologies to a third-party rival .
- Pharma may prove to be the Little Miss SunshineBuoyed by overseas acquisitions and strong growth in key international markets, pharma companies could see an overall 38% increase in net p...
Load More
